Hemocept Inc.
Clinical trials sponsored by Hemocept Inc., explained in plain language.
-
New device aims to take the guesswork out of dialysis
Diagnosis CompletedThis small, completed study tested a new device called HemoCept. Researchers wanted to see if the device could accurately measure how much fluid is removed from a patient's body during dialysis treatment. The study involved 12 adults with end-stage kidney disease who were already…
Sponsor: HemoCept Inc. • Aim: Diagnosis
Last updated Apr 04, 2026 00:05 UTC
-
New device could help dialysis patients track fluid removal
Knowledge-focused CompletedThis small pilot study tested whether a new device called HemoCept could accurately measure fluid removal during dialysis treatments. Researchers enrolled 26 adults with end-stage kidney disease who had been on dialysis for at least 90 days. The study compared the device's readin…
Sponsor: HemoCept Inc. • Aim: Knowledge-focused
Last updated Apr 04, 2026 00:05 UTC